|
GEMIN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.474400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.697610E-01 |
| Normal-vs-Stage2 |
7.341900E-02 |
| Normal-vs-Stage3 |
2.129400E-01 |
| Normal-vs-Stage4 |
5.134100E-02 |
| Stage1-vs-Stage2 |
3.496100E-03 |
| Stage1-vs-Stage3 |
2.835100E-03 |
| Stage1-vs-Stage4 |
6.169600E-04 |
| Stage2-vs-Stage3 |
5.090400E-01 |
| Stage2-vs-Stage4 |
9.988600E-01 |
| Stage3-vs-Stage4 |
4.519200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.051400E-01 |
| Normal-vs-AfricanAmerican |
8.563400E-01 |
| Normal-vs-Asian |
8.366600E-01 |
| Caucasian-vs-AfricanAmerican |
5.765200E-01 |
| Caucasian-vs-Asian |
7.571600E-01 |
| AfricanAmerican-vs-Asian |
9.440200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.234000E-01 |
| Normal-vs-Female |
4.202600E-01 |
| Male-vs-Female |
1.687530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.212800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.537800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.403800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.746010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.799400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.728000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.207200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.698400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.790400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.897390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.199900E-03 |
| Normal-vs-Grade 2 |
2.060200E-01 |
| Normal-vs-Grade 3 |
1.447800E-01 |
| Normal-vs-Grade 4 |
6.521800E-02 |
| Grade 1-vs-Grade 2 |
3.111700E-02 |
| Grade 1-vs-Grade 3 |
1.792420E-04 |
| Grade 1-vs-Grade 4 |
5.577300E-04 |
| Grade 2-vs-Grade 3 |
4.045300E-04 |
| Grade 2-vs-Grade 4 |
1.376310E-03 |
| Grade 3-vs-Grade 4 |
3.709000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.787800E-02 |
| Normal-vs-ccB subtype |
1.334400E-01 |
| ccA subtype-vs-ccB subtype |
1.376150E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.422800E-01 |
| Normal-vs-N1 |
8.950000E-01 |
| N0-vs-N1 |
6.662800E-01 |
|
|
